BioSpace News Archive

The expert ‘Peer Exchange’ panel will discuss the evolving landscape of Alzheimer’s treatment

MedinCell partners with Cornerstone Animal Health to develop a range of best-in-class long-acting injectable veterinary products using MedinCell’s BEPO® proprietary technology.

Orbis International today announced the appointment of Danusia Dzierzbinski as Chief Financial Officer.

4WEB Medical, an orthopedic device company focused on developing innovative implants utilizing its proprietary Truss Implant Technology™, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Cervical Spine Truss System-Stand Alone (CSTS-SA) Interbody Fusion Device.

PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has solidified its leadership position in the EU with strategic investment to deepen its presence in Ireland and expand its European foothold.

“Hepatitis C virus remains a significant public health issue, but effective therapeutic options have helped patients to receive important curative treatments,” said Debra Birnkrant, M.D., director of the Division of Antiviral Products within the FDA’s Center for Drug Evaluation and Research.

The Crohn’s & Colitis Foundation’s New England Chapter proudly announces its 50th anniversary, commemorating five decades of volunteer leadership, research initiatives, disease awareness, patient support, and advocacy programs.

Neurocrine Biosciences, Inc. announced that Neurocrine Biosciences management will present at the following investor conferences

REGENXBIO Inc. announced that it will present at the following September investor conferences

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 17th Annual Morgan Stanley Global Healthcare Conference in New York.